Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P1.02 - Poster Session/ Treatment of Localized Disease – NSCLC

    • Type: Poster
    • Track: Treatment of Localized Disease - NSCLC
    • Presentations: 39
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.02-012 - Study for Prognostic Impact of Tumor Volume Instead of Tumor Size for T Staging in NSCLCancer

      09:30 - 09:30  |  Author(s): D. Kim

      • Abstract

      Loading...

  • +

    ORAL 10 - SCLC

    • Type: Oral Session
    • Track: Small Cell Lung Cancer
    • Presentations: 9
    • Moderators:C. Faivre-Finn
    • Coordinates: 9/07/2015, 10:45 - 12:15, 605+607
  • +

    ORAL 13 - Immunotherapy Biomarkers

    • Type: Oral Session
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 8
    • Moderators:D. Kim
    • Coordinates: 9/07/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
    • +

      ORAL13.01 - PD-L1 Expression in Lung Adenocarcinomas Correlates with KRAS Mutations and Th1/Cytotoxic T Lymphocyte Microenvironment

      16:45 - 16:56  |  Author(s): T. Huynh

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL13.02 - Characterization of PD-L1 Expression Related to Unique Genes in NSCLC Tissue Samples

      16:56 - 17:07  |  Author(s): E.B. Garon

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL13.03 - Spatiotemporal Effects on Programmed Death Ligand 1 (PD-L1) Expression and Immunophenotype of Non-Small Cell Lung Cancer (NSCLC)

      17:07 - 17:18  |  Author(s): M. Kowanetz

      • Abstract

      Loading...

    • +

      ORAL13.04 - Discussant for ORAL13.01, ORAL13.02, ORAL13.03

      17:18 - 17:28  |  Author(s): S.N. Gettinger

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL13.05 - Predictive Biomarker Testing for Programmed Cell Death 1 Inhibition in Non-Small Cell Lung Cancer

      17:28 - 17:39  |  Author(s): B.S. Sheffield

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL13.06 - Programmed Death Ligand-1 (PDL-1) Expression in Non-Small Cell Lung Cancer (NSCLC): Analysis of a Large Early Stage Cohort; and Concordance of Expression in Paired Primary-Nodal and Primary-Metastasis Tumour Samples

      17:39 - 17:50  |  Author(s): P. Mitchell

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL13.07 - EMT Is Associated with an Inflammatory Tumor Microenvironment with Elevation of Immune Checkpoints and Suppressive Cytokines in Lung Cancer

      17:50 - 18:01  |  Author(s): Y. Lou

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL13.08 - Discussant for ORAL13.05, ORAL13.06, ORAL13.07

      18:01 - 18:11  |  Author(s): D. Rimm

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 102
    • Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P2.01-086 - Ceritinib in ALK+ NSCLC Metastatic to Brain and/or Leptomeninges: The ASCEND-7 Study

      09:30 - 09:30  |  Author(s): L.Q. Chow

      • Abstract

      Loading...

    • +

      P2.01-094 - Phase II Trial of Tepotinib/Gefitinib vs Cisplatin/Pemetrexed in T790M-/c-Met+ NSCLC

      09:30 - 09:30  |  Author(s): Y. Wu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 16 - EGFR Mutant Lung Cancer 2

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:G.J. Riely
    • Coordinates: 9/08/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
  • +

    P3.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 91
    • Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P3.01-011 - Antitumor Activity of Tepotinib plus Gefitinib in Asian Patients with Met+ EGFRm+ NSCLC

      09:30 - 09:30  |  Author(s): D. Kim

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P3.01-077 - A Randomized, Phase II Study of Nimotuzumab Plus Gefitinib vs Gefitinib in Advanced Non-Small Cell Lung Cancer After Platinum- Based Chemotherapy

      09:30 - 09:30  |  Author(s): H.R. Kim

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.04 - Poster Session/ Biology, Pathology, and Molecular Testing

    • Type: Poster
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 134
    • Coordinates: 9/09/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P3.04-134 - Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and its Potential as a Biomarker

      09:30 - 09:30  |  Author(s): T. Lou

      • Abstract

      Loading...

  • +

    MINI 26 - Circulating Tumor Markers

    • Type: Mini Oral
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 14
    • Moderators:M. Macmanus
    • Coordinates: 9/09/2015, 16:45 - 18:15, 205+207
    • +

      MINI26.11 - Longitudinal Monitoring of EGFR Mutations in Plasma of EGFR Mutant NSCLC Patients Treated with EGFR TKIs: Korean Lung Cancer Consortium

      17:40 - 17:45  |  Author(s): J.Y. Lee

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 33 - ALK

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:S. Gadgeel
    • Coordinates: 9/09/2015, 16:45 - 18:15, Mile High Ballroom 1a-1f
  • +

    MINI 31 - ALK

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:S. Malik
    • Coordinates: 9/09/2015, 18:30 - 20:00, Mile High Ballroom 1a-1f